X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

MEDICAL ONCOLOGY

期刊標題檢索 MED ONCOL 最新評論: What happened later? (2024-10-27)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[MEDICAL ONCOLOGY]您好,您是該頁面的第 105177 位訪客。

期刊簡介
期刊名稱MEDICAL ONCOLOGY MEDICAL ONCOLOGY
LetPub Score
6.4
50 ratings
Rate

Reputation
7.6

Influence
5.2

Speed
7.1

期刊簡稱MED ONCOL
ISSN1357-0560
E-ISSN1559-131X
h-index64
CiteScore
CiteScoreSJRSNIPCiteScore Rank
4.200.7630.623
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Hematology
Q263 / 137
Category: Medicine
Subcategory: Oncology
Q2194 / 404
Category: Medicine
Subcategory: Cancer Research
Q3145 / 230

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
Medical Oncology (MO) communicates the results of clinical and experimental research in oncology and hematology, particularly experimental therapeutics within the fields of immunotherapy and chemotherapy. It also provides state-of-the-art reviews on clinical and experimental therapies. Topics covered include immunobiology, pathogenesis, and treatment of malignant tumors.
官方網站https://www.springer.com/12032
在線稿件提交https://www.editorialmanager.com/medo/
開放訪問No
出版商Springer US
主題領域医学
出版國/地區UNITED STATES
發行頻率四半期刊行
創刊年1984
每年文章數323每年文章數趨勢
黃金OA百分比13.14%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ2157/322
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1357-0560%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 1.4 Month(s)
競爭力 *來自作者的數據: About 63.33%
參考鏈接
相關期刊 【MEDICAL ONCOLOGY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    ANNALS OF ONCOLOGYH-index: 210

    CiteScore: 63.90
    CANCER CELLH-index: 295

    CiteScore: 55.20
    JOURNAL OF CLINICAL ONCOLOGYH-index: 494

    CiteScore: 41.20
    LANCET ONCOLOGYH-index: 274

    CiteScore: 62.10
    CANCER RESEARCHH-index: 411

    CiteScore: 16.10
    SEMINARS IN CANCER BIOLOGYH-index: 134

    CiteScore: 26.80
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCHH-index: 67

    CiteScore: 18.20
    學科內最受檢索的期刊 頁面查看次數
    CANCER LETTERS338157
    CANCER RESEARCH313851
    Asian Pacific Journal of Cancer Prevention258531
    BMC CANCER249446
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH198292
    INTERNATIONAL JOURNAL OF CANCER196264
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY183904
    CLINICAL CANCER RESEARCH183691
    ONCOLOGY REPORTS180189
    CA-A CANCER JOURNAL FOR CLINICIANS164550
  •  

    MEDICAL ONCOLOGY MEDICAL ONCOLOGY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/23)
  [MEDICAL ONCOLOGY] 的評論撰寫評論
作者: 岳家寄波


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-27 18:24:42 評論於
What happened later?
(0) 讚! | 岳家寄波

作者: 岳家寄波


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-27 13:31:29 評論於
Research focus: Tumor experience sharing: May I ask how the review speed is for newly submitted papers? It has been ten days and there has been no response.
(0) 讚! | 岳家寄波

作者: Dr.liuhuanxiang


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2024-10-24 14:46:46 評論於
Brother, may I ask how many days after you receive the proof, approximately how long will it take to retrieve it?
(0) 讚! | Dr.liuhuanxiang

作者: 咏春俊贺


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-09 21:25:13 評論於
Was it submitted for review later?
(0) 讚! | 咏春俊贺

作者: 小晶燕吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-08 15:05:00 評論於
The meta-analysis on nasopharyngeal carcinoma was rejected three days ago.
(0) 讚! | 小晶燕吖

作者: 百花念柏


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-16 10:25:42 評論於
Hey, is this fast or not?
(0) 讚! | 百花念柏

作者: codymtt


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-31 21:02:12 評論於
Submitted, after passing the qualification review on the same day, it has been a month and there has been no change. It should have been sent for external review. Continuously updating
(0) 讚! | codymtt

作者: 法慧寻菡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-27 13:06:17 評論於
Before submitting, they always ask for changes to this format or that format, each magazine has its own format. Can they agree to accept the submission first and then adjust the format?
(0) 讚! | 法慧寻菡

作者: 月河啸天


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-08 23:51:10 評論於
How long does peer review take?
(0) 讚! | 月河啸天

作者: 华清迎夏


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-04 20:22:01 評論於
Brother, how long does it take to receive the proof? It's been almost 3 weeks and I still haven't received it
(0) 讚! | 华清迎夏

作者: 华清迎夏


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-04 17:50:23 評論於
May I ask how long it takes for the magazine to receive the proofs? It has been almost 3 weeks and I have not heard anything back
(0) 讚! | 华清迎夏

作者: 努力啊大若星


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-19 16:03:57 評論於
Hello, how can I contact you?
(0) 讚! | 努力啊大若星

作者: 四风友海


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-27 18:30:51 評論於
Review Speed: 1.0 | Submission Acceptance Rate: 95.0
Experience Sharing: A pretty good journal
(0) 讚! | 四风友海

作者: 吉恩萨皮尔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-16 11:14:15 評論於
It's been 15 days and there's been no movement. Is it a tragedy?
(0) 讚! | 吉恩萨皮尔

作者: 太山天震


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-17 20:50:10 評論於
Hello, when can I be assigned an editor?
(0) 讚! | 太山天震

作者: 太山天震


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-17 16:12:20 評論於
Hello, may I ask if you submitted this on the Springer Nature website?
(0) 讚! | 太山天震

作者: 万花思丝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-05 10:22:56 評論於
Thank you, I also received the galley proof email after about a month. The galley proof was quickly indexed on PubMed. I couldn't wait in between, so I sent an email and the responses were very prompt
(0) 讚! | 万花思丝

作者: 小涛可爱吗


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-28 16:47:15 評論於
I have finished editing the manuscript for a month, and will send the proof around 11.27 to 12.26
(0) 讚! | 小涛可爱吗

作者: 北海毅然


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-24 11:38:42 評論於
Research focus: Basic tumor experience sharing: 2023.10.13 submitted2023.10.22 Under Review2023.11.8 major revise2023.12.17 resubmitted2023.12.18 accept
(0) 讚! | 北海毅然

作者: 上清明喆


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-22 15:58:36 評論於
Now Christmas holidays are even quieter
(0) 讚! | 上清明喆

作者: 万花思丝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-18 23:23:07 評論於
Excuse me, has your article been officially published? After a paper is accepted, how long does it take for proofreading and then posting online? I don't want to pay the OA fees, they are too expensive. The editor sent an email saying the article was accepted, but it's been over ten days and there has been no proofreading or any updates
(0) 讚! | 万花思丝

作者: 万花思丝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-18 15:55:34 評論於
How long does it take to proofread and put the article online after it is accepted? I don't want to pay the OA fee, it's too expensive. The editor sent an email saying that the article has been accepted, but it's been more than 10 days and there's still no proofreading, no updates
(0) 讚! | 万花思丝

作者: 暴风颖昕


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-22 22:37:31 評論於
Do you have it?
(0) 讚! | 暴风颖昕

作者: 暴风颖昕


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-22 11:19:10 評論於
Do you have it?
(0) 讚! | 暴风颖昕

作者: 天山兴昌


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-16 13:09:40 評論於
Two months of Under Review, no comments, just rejected. Too harsh
(0) 讚! | 天山兴昌

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/23)

開始撰寫 [MEDICAL ONCOLOGY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*